August 31, 2026
HEOR Strategic Priorities for Pricing and Access Leaders
Senior leaders in health economics and market access now confront a crowded agenda…
August 24, 2026
Rethinking Employer Health Costs for Sustainable Access
Sustained growth in employer health costs is no longer a narrow benefits issue.…
August 17, 2026
SINACC Access Reform: What the Delay Signals for Market Access
Portugal's SINACC Access Reform, built around the Sistema Nacional de Acesso a Consulta…
August 10, 2026
PRIME Scheme and the SME Gap: What July 2026’s Outcomes Reveal
The European Medicines Agency published its latest recommendations on PRIME scheme SME eligibility…
August 3, 2026
EMA-EFPIA Ninth Bilateral Meeting: Europe’s Pharmaceutical Access Crisis and the Road to Reform
On 16 September 2026, the European Medicines Agency (EMA) and the European Federation…
July 27, 2026
MFN Pricing Readiness When Patients Pay for Delay
Most Favoured Nation rules often centre on rebates and reference pricing, yet patients…